<DOC>
	<DOCNO>NCT00908713</DOCNO>
	<brief_summary>The purpose study assess efficacy glucocorticoid adjuvant therapy patient severe community-acquired pneumonia ( CAP ) ( Fine V ) . The hypothesis study glucocorticoid modulate excessive inflammatory response patient severe CAP without significant side effect , show benefit percentage non-response empiric antimicrobial treatment .</brief_summary>
	<brief_title>Corticoids Severe Community-Acquired Pneumonia ( CAP )</brief_title>
	<detailed_description>Community acquire pneumonia ( CAP ) associate local systemic inflammatory response conduct different pro counter inflammatory cytokine . The evolution infection mainly dependent intensity inflammatory response . The AIM project determine clinical usefulness methylprednisolone treatment ( 0,5 mg/ Kg weight every 12h 5 day patient severe CAP excessive inflammatory response ( patient identify base cut-off point reactive C protein ( RCP ) 15 mg/dl ) . A randomized double blind placebo control study two arm perform : The study group ( patient excessive inflammatory response ) receive methylprednisolone + antibiotic . Control group receive placebo + antibiotic . Patients older 18 year Fine V pneumonia recruit . Clinical data prognostic factor ( APACHE II , SOFA score , etiology , mortality ICU 28 day ) collect .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Severe communityacquired pneumonia Fine V CRP &gt; =15 mg/100 mL Major contraindication corticosteroid , uncontrolled diabetes , immunosuppression Previous glucocorticoid treatment previous month Documented extrapulmonary infection Previous hospitalization previous month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Severe CAP</keyword>
	<keyword>Adjuvant therapy</keyword>
	<keyword>Glucocorticoids</keyword>
	<keyword>CAP Fine V C-reactive protein &gt; = 15 mg/100 mL</keyword>
</DOC>